Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dare Bioscience, Inc. - Common Stock
(NQ:
DARE
)
1.860
-0.030 (-1.59%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dare Bioscience, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 21, 2024
Via
Benzinga
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
↗
May 17, 2024
Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.
Via
Benzinga
DARE Stock Earnings: Dare Bioscience Misses EPS, Beats Revenue for Q1 2024
↗
May 14, 2024
DARE stock results show that Dare Bioscience missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
April 25, 2024
Via
Benzinga
Recap: Dare Bioscience Q4 Earnings
↗
March 28, 2024
Via
Benzinga
Dare Bioscience Earnings Preview
↗
March 27, 2024
Via
Benzinga
Earnings Outlook For Dare Bioscience
↗
November 08, 2023
Via
Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 24, 2024
Via
Benzinga
Earnings Outlook For Dare Bioscience
↗
August 09, 2023
Via
Benzinga
Recap: Dare Bioscience Q1 Earnings
↗
May 11, 2023
Via
Benzinga
Earnings Outlook For Dare Bioscience
↗
May 10, 2023
Via
Benzinga
Earnings Preview: Dare Bioscience
↗
March 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
March 28, 2024
Via
Benzinga
DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023
↗
March 28, 2024
DARE stock results show that Dare Bioscience beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
↗
February 21, 2024
Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
February 01, 2024
It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!
Via
InvestorPlace
Earnings Scheduled For March 28, 2024
↗
March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via
Benzinga
Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation
↗
December 20, 2023
Daré Bioscience Inc (NASDAQ: DARE) announced topline results from the Phase 1 DARE-PDM1-001 study evaluating the pharmacokinetics (PK), safety, and exploratory efficacy of DARE-PDM1 an investigational...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 20, 2023
Via
Benzinga
FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
↗
December 07, 2023
Daré Bioscience Inc (NASDAQ: DARE) announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option for moderate to severe dyspareunia,...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 20, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
July 31, 2023
On Monday, 27 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
July 21, 2023
On Friday, 54 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 17, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
April 03, 2023
We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.